Ultramox 500 500 mg Capsules
PDF Leaflet Revision Date: 12 November 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Infections caused by susceptible, non-penicillinase-producing organisms.
Dosage (summary)
Adults: 250 mg three times daily; up to 6 g daily in severe infections.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy not established; use with caution in breastfeeding.
Key Drug Interactions
- Anticoagulants
- Allopurinol
- Methotrexate
- Probenecid
Contraindications
- Hypersensitivity to penicillins
- History of hypersensitivity to u03b2-lactam antibiotics
Common side effects
- Diarrhoea
- Nausea
- Vomiting
- Skin rashes
- Headache
Counselling Points
- Take with water without opening capsule
- Maintain adequate fluid intake
- Monitor for allergic reactions
Serious warnings
- Serious hypersensitivity reactions
- Risk of antibiotic-associated colitis
Important Disclaimer
The Ultramox 500 500 mg Capsules professional information leaflet below is the property of Oethmaan Biosims and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
